Brokerages expect Phibro Animal Health (NASDAQ:PAHC) to announce earnings of $0.45 per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Phibro Animal Health’s earnings. The highest EPS estimate is $0.45 and the lowest is $0.44. Phibro Animal Health reported earnings per share of $0.39 in the same quarter last year, which would suggest a positive year over year growth rate of 15.4%. The company is scheduled to issue its next quarterly earnings results on Wednesday, August 29th.
According to Zacks, analysts expect that Phibro Animal Health will report full year earnings of $1.71 per share for the current fiscal year, with EPS estimates ranging from $1.70 to $1.73. For the next fiscal year, analysts anticipate that the firm will report earnings of $1.89 per share, with EPS estimates ranging from $1.86 to $1.90. Zacks’ EPS averages are a mean average based on a survey of research firms that cover Phibro Animal Health.
Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, May 7th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.44 by $0.02. Phibro Animal Health had a net margin of 7.24% and a return on equity of 41.29%. The company had revenue of $209.00 million for the quarter, compared to the consensus estimate of $203.03 million. During the same period in the prior year, the firm posted $0.37 EPS. Phibro Animal Health’s revenue for the quarter was up 10.0% on a year-over-year basis.
Several analysts recently commented on PAHC shares. BidaskClub downgraded shares of Phibro Animal Health from a “sell” rating to a “strong sell” rating in a research report on Friday, January 26th. Credit Suisse Group upped their target price on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, February 6th. Morgan Stanley upped their target price on shares of Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a research note on Wednesday, February 7th. Zacks Investment Research upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 target price on the stock in a research note on Thursday, February 8th. Finally, ValuEngine upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Wednesday, February 28th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $38.80.
In other Phibro Animal Health news, major shareholder Bfi Co., Llc sold 12,000 shares of the company’s stock in a transaction dated Wednesday, March 14th. The shares were sold at an average price of $40.12, for a total transaction of $481,440.00. Following the transaction, the insider now owns 24,000 shares in the company, valued at approximately $962,880. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Dean J. Warras sold 10,000 shares of the company’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $35.62, for a total transaction of $356,200.00. Following the transaction, the insider now owns 10,000 shares in the company, valued at approximately $356,200. The disclosure for this sale can be found here. Insiders have sold a total of 276,056 shares of company stock worth $10,495,260 in the last 90 days. Company insiders own 51.88% of the company’s stock.
Large investors have recently modified their holdings of the company. Goldman Sachs Group Inc. lifted its stake in shares of Phibro Animal Health by 17.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 476,391 shares of the company’s stock worth $15,959,000 after purchasing an additional 69,063 shares during the period. California Public Employees Retirement System lifted its stake in shares of Phibro Animal Health by 9.5% in the 3rd quarter. California Public Employees Retirement System now owns 44,994 shares of the company’s stock worth $1,667,000 after purchasing an additional 3,894 shares during the period. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Phibro Animal Health by 37.4% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 243,550 shares of the company’s stock worth $8,159,000 after purchasing an additional 66,300 shares during the period. Investors Research Corp bought a new position in shares of Phibro Animal Health in the 4th quarter worth approximately $433,000. Finally, Crossmark Global Holdings Inc. bought a new position in shares of Phibro Animal Health in the 4th quarter worth approximately $253,000. Hedge funds and other institutional investors own 48.25% of the company’s stock.
PAHC stock traded down $0.20 during trading on Friday, hitting $44.05. 2,969 shares of the stock traded hands, compared to its average volume of 100,831. Phibro Animal Health has a 1 year low of $43.90 and a 1 year high of $45.17. The company has a market capitalization of $1.69 billion, a price-to-earnings ratio of 29.30, a price-to-earnings-growth ratio of 2.99 and a beta of 0.92. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.75 and a current ratio of 3.12.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 27th. Shareholders of record on Wednesday, June 6th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 0.91%. The ex-dividend date is Tuesday, June 5th. Phibro Animal Health’s dividend payout ratio is currently 26.49%.
About Phibro Animal Health
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.
Get a free copy of the Zacks research report on Phibro Animal Health (PAHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.